Edition:
United States

Anika Therapeutics Inc (ANIK.OQ)

ANIK.OQ on NASDAQ Stock Exchange Global Select Market

54.77USD
21 Nov 2017
Change (% chg)

-- (--)
Prev Close
$54.77
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
35,696
52-wk High
$60.28
52-wk Low
$41.64

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 27.18 0.456
Jun '17 33.46 0.756
Mar '17 23.39 0.365
FY 2016 Dec '16 28.73 0.540
Sep '16 25.79 0.594
Jun '16 26.58 0.570
Mar '16 22.28 0.450
FY 2015 Dec '15 30.89 0.719
Sep '15 23.68 0.547
Jun '15 22.90 0.510
Mar '15 15.52 0.229
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 2 30.22 30.38 30.07 32.50
Quarter Ending Mar-18 2 25.06 25.30 24.81 --
Year Ending Dec-17 2 114.25 114.41 114.10 116.59
Year Ending Dec-18 2 119.14 122.60 115.68 123.06
Earnings (per share)
Quarter Ending Dec-17 2 0.46 0.47 0.45 0.61
Quarter Ending Mar-18 2 0.31 0.34 0.29 --
Year Ending Dec-17 2 2.04 2.05 2.02 2.14
Year Ending Dec-18 2 1.83 2.01 1.65 2.15
LT Growth Rate (%) 1 10.00 10.00 10.00 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 25.88 31.69 34.95
P/E High - Last 5 Yrs. 27.50 40.50 45.20
P/E Low - Last 5 Yrs. 12.13 23.60 24.25
Beta 1.47 0.91 0.89
Price to Sales (TTM) 7.12 3.88 5.33
Price to Book (MRQ) 3.17 4.82 5.62
Price to Tangible Book (MRQ) 3.43 5.63 7.14
Price to Cash Flow (TTM) 22.30 22.94 23.84
% Owned Institutions 87.12 0.74 1.28

Dividends

  Company industry sector
Dividend Yield -- 1.55 1.48
Dividend Yield - 5 Year Avg -- 2.15 2.03
Dividend 5 Year Growth Rate -- 4.36 5.30
Payout Ratio(TTM) 0.00 46.46 45.36

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 5.41 6.29 6.90
Sales (TTM) vs TTM 1 Yr. Ago 6.83 4.65 5.13
Sales - 5 Yr. Growth Rate 9.80 10.15 10.38
EPS (MRQ) vs Qtr. 1 Yr. Ago -23.26 4.30 4.83
EPS (TTM) vs TTM 1 Yr. Ago -9.31 -- --
EPS - 5 Yr. Growth Rate 28.45 10.02 11.02
Capital Spending - 5 Yr. Growth Rate 58.51 15.20 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 15.27 2.49 2.54
Current Ratio (MRQ) 17.00 3.51 3.56
LT Debt to Equity (MRQ) 0.00 9.82 12.21
Total Debt to Equity (MRQ) 0.00 15.87 18.21
Interest Coverage (TTM) -- 48.47 43.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 76.78 54.98 54.70
Gross Margin - 5 Yr. Avg. 73.74 52.07 52.23
EBITD Margin (TTM) 46.93 -- --
EBITD - 5 Yr. Avg 52.71 18.38 15.73
Operating Margin (TTM) 43.23 14.67 8.12
Operating Margin - 5 Yr. Avg. 47.39 14.49 11.38
Pre-Tax Margin (TTM) 43.57 15.13 8.97
Pre-Tax Margin - 5 Yr. Avg. 47.42 14.81 11.79
Net Profit Margin (TTM) 28.23 11.30 5.20
Net Profit Margin - 5 Yr. Avg. 29.87 11.13 8.07
Effective Tax Rate (TTM) 35.20 24.30 24.20
Effective Tax Rate - 5 Yr. Avg. 37.00 23.45 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 924,246 963,521,863 868,183,395
Net Income/Employee (TTM) 260,934 112,484,218 101,277,770
Receivable Turnover (TTM) 4.94 5.83 6.13
Inventory Turnover (TTM) 1.37 2.72 3.51
Asset Turnover (TTM) 0.45 1.00 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 12.63 11.96 11.42
Return on Assets - 5 Yr. Avg. 14.65 13.04 12.45
Return on Investment (TTM) 13.13 15.18 14.58
Return on Investment - 5 Yr. Avg. 15.65 17.06 16.30
Return on Equity (TTM) 13.61 16.59 16.08
Return on Equity - 5 Yr. Avg. 16.91 18.00 17.45
  1 Year 3 Year 5 Year
Sales % 11.16 11.25 9.80
EPS (TTM) % 7.25 15.77 28.45
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Anika Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -8.09 -9.15 21 28
13 Week 3.34 -2.49 48 12
26 Week 18.01 8.90 77 29
52 Week 19.04 0.68 63 23
YTD 11.87 -3.64 61 23
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 87.12%
# of Holders: 246
Total Shares Held: 12,773,790
3 Mo. Net Change: 90,618
# New Positions: 24
# Closed Positions: 17
# Increased Positions: 98
# Reduced Positions: 82
# Net Buyers: 16
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.